Skip to content

Retinopathy Of Prematurity Zone Ii C4703699

Published: July 22, 2026Updated: August 20, 2026

An eye disease affecting premature infants where abnormal blood vessels grow in the retina. Early detection and treatment with laser or injections can help prevent permanent vision loss.

Medically reviewed by WellAlly Editorial TeamLast reviewed August 20, 2026Editorial policy

Key facts at a glance

ICD-10
H53.9
ICD-11
9A00.0
Body system
ophthalmologic
Severity
moderate
Chronic
true

Signs and symptoms

Common signs and symptoms that may indicate this condition.

Warning signs - seek immediate care

!

Retinal detachment

!

Leukocoria

!

Reduced visual acuity

Generalized symptoms

(ophthalmologic)

Noticeable symptoms that may vary in intensity over time.

Frequency: Common at all stages

Abnormal retinal vascularization

(ophthalmologic)

Diagnosis and tests

How this condition is diagnosed and what test results mean.

Initial screening tests

1

Standard diagnostic workup

Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]

Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]

Treatment options

Evidence-based approaches to managing this condition.

First-line treatments

1

Dietary counseling and physical activity plan

Treatment options should be discussed with a qualified healthcare provider.

lifestyle
2

Laser photocoagulation

Laser therapy is applied to the peripheral retina to reduce abnormal blood vessel growth and prevent progression of retinopathy. This outpatient procedure is performed under anesthesia in premature infants.

procedure
3

Anti-VEGF intravitreal injections

Vascular endothelial growth factor inhibitors are injected into the eye to block abnormal blood vessel formation. This treatment may be used alone or in combination with laser therapy for advanced cases.

medication

Additional treatment options

Cryotherapy

Cryotherapy involves freezing abnormal retinal tissue to destroy it and reduce vascular proliferation. This treatment is typically reserved for cases where laser therapy is not feasible.

procedure

Regular ophthalmologic screening

Serial eye examinations by a pediatric ophthalmologist are essential for detecting progression and determining optimal treatment timing. Imaging technologies help track disease evolution.

monitoring

Vitrectomy

Surgical removal of the vitreous and scar tissue may be necessary for advanced cases with retinal detachment. This complex procedure is reserved for severe ROP that does not respond to other treatments.

surgical

When to seek medical help

Recognize when you need immediate medical attention.

Schedule an appointment soon

Symptoms associated with this condition. Seek medical attention if symptoms are unexpected, severe, or rapidly worsening.- Contact your healthcare provider if symptoms persist or worsen. Seek emergency care for sudden severe symptoms.

Frequently asked questions

Common questions about this topic.

Q

What is Retinopathy Of Prematurity Zone Ii C4703699?

Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]

general

Sources and references

Authoritative medical sources used to create this content.

1

Fierson WM, American Academy of Pediatrics Section on Ophthalmology. Screening examination of premature infants for retinopathy of prematurity. Pediatrics. 2018.

guideline2018
2

Chen ML, Stahl A, Hellstrom A. Current update on retinopathy of prematurity: screening and treatment. Eye. 2021.

review2021
3

Mintz-Hittner HA, Kennedy KA, Chuang AZ. Efficacy of intravitreal bevacizumab for stage 3+ retinopathy of prematurity. N Engl J Med. 2011.

clinical_trial2011
4

Sankar MJ, Sankar J, Mehta M. Anti-vascular endothelial growth factor for type 1 retinopathy of prematurity: a systematic review and meta-analysis. JAMA Ophthalmol. 2022.

meta_analysis2022

Medication Comparisons

Compare medications used to treat Retinopathy Of Prematurity Zone Ii C4703699. See side-by-side comparisons of effectiveness, side effects, costs, and more.

View Medication Comparisons

This information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.

Medical Disclaimer

This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.

If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.

Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy